|
1
|
Li Y, Yan PW, Huang XE and Li CG: MDR1
gene C3435T polymorphism is associated with clinical outcomes in
gastric cancer patients treated with postoperative adjuvant
chemotherapy. Asian Pac J Cancer Prev. 12:2405–2409.
2011.PubMed/NCBI
|
|
2
|
Ferro A, Peleteiro B, Malvezzi M, Bosetti
C, Bertuccio P, Levi F and Negri E: LaV ecchia C and Lunet N:
Worldwide trends in gastric cancer mortality (1980-2011), with
predictions to 2015, and incidence by subtype. Eur J Cancer.
50:1330–1344. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
American Cancer Society Survival rates for
stomach cancer by stage. https://www.cancer.org/cancer/stomach-cancer/detection-diagnosis-staging/survival-rates.htmlAccessed.
June 24–2014
|
|
4
|
Shan YS, Hsu HP, Lai MD, Yen MC, Luo YP
and Chen YL: Increased expression of argininosuccinate synthetase
protein predicts poor prognosis in human gastric cancer. Oncology
Rep. 33:49–57. 2015.
|
|
5
|
Yuan J, Li W, Tian Y and Wang X:
Anti-proliferative effect of Flos Albiziae flavonoids on the human
gastric cancer SGC-7901 cell line. Exp Ther Med. 5:51–56.
2013.PubMed/NCBI
|
|
6
|
Romagnolo DF and Selmin OI: Flavonoids and
cancer prevention: A review of the evidence. J Nutr Gerontol
Geriatr. 31:206–238. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ekambaram G, Rajendran P, Magesh V and
Sakthisekaran D: Naringenin reduces tumor size and weight lost in
N-methyl-N'-nitro-N-nitrosoguanidine-induced gastric carcinogenesis
in rats. Nutr Res. 28:106–112. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liao AC, Kuo CC, Huang YC, Yeh CW, Hseu
YC, Liu JY and Hsu LS: Naringenin inhibits migration of bladder
cancer cells through downregulation of AKT and MMP2. Mol Med Rep.
10:1531–1536. 2014.PubMed/NCBI
|
|
9
|
Hatkevich T, Ramos J, Santos-Sanchez I and
Patel YM: A naringenin-tamoxifen combination impairs cell
proliferation and survival of MCF-7 breast cancer cells. Exp Cell
Res. 327:331–339. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ahamad MS, Siddiqui S, Jafri A, Ahmad S,
Afzal M and Arshad M: Induction of apoptosis and antiproliferative
activity of naringenin in human epidermoid carcinoma cell through
ROS generation and cell cycle arrest. PloS one. 9:e1100032014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Arul D and Subramanian P: Naringenin
(citrus flavonone) induces growth inhibition cell cycle arrest and
apoptosis in human hepatocellular carcinoma cells. Pathol Oncol
Res. 19:763–770. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kang MH and Reynolds CP: Bcl-2 inhibitors:
Targeting mitochondrial apoptotic pathways in cancer therapy. Clin
Cancer Res. 15:1126–1132. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tahir SK, Yang X, Anderson MG,
Morgan-Lappe SE, Sarthy AV, Chen J, Warner RB, Ng SC, Fesik SW,
Elmore SW, et al: Influence of Bcl-2 family members on the cellular
response of small-cell lung cancer cell lines to ABT-737. Cancer
Res. 67:1176–1183. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Konopleva M, Contractor R, Tsao T, Samudio
I, Ruvolo PP, Kitada S, Deng X, Zhai D, Shi YX, Sneed T, et al:
Mechanisms of apoptosis sensitivity and resistance to the BH3
mimetic ABT-737 in acute myeloid leukemia. Cancer Cell. 10:375–388.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bodet L, Gomez-Bougie P, Touzeau C,
Dousset C, Descamps G, Maïga S, Avet-Loiseau H, Bataille R, Moreau
P, Le Gouill S, et al: ABT-737 is highly effective against
molecular subgroups of multiple myeloma. Blood. 118:3901–3910.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
van Delft MF, Wei AH, Mason KD, Vandenberg
CJ, Chen L, Czabotar PE, Willis SN, Scott CL, Day CL, Cory S, et
al: The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and
efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized.
Cancer cell. 10:389–399. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sun XP, Zhang X, He C, Qiao H, Jiang X,
Jiang H and Sun X: ABT-737 synergizes with arsenic trioxide to
induce apoptosis of gastric carcinoma cells in vitro and in vivo. J
Int Med Res. 40:1251–1264. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li RF, Feng YQ, Chen JH, Ge LT, Xiao SY
and Zuo XL: Naringenin suppresses K562 human leukemia cell
proliferation and ameliorates Adriamycin-induced oxidative damage
in polymorphonuclear leukocytes. Exp Ther Med. 9:697–706.
2015.PubMed/NCBI
|
|
19
|
Park JH, Jin CY, Lee BK, Kim GY, Choi YH
and Jeong YK: Naringenin induces apoptosis through downregulation
of Akt and caspase-3 activation in human leukemia THP-1 cells. Food
Chem Toxicol. 46:3684–3690. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Parrondo R: deL as Pozas A, Reiner T and
Perez-Stable C: ABT-737, a small molecule Bcl-2/Bcl-xL antagonist,
increases antimitotic-mediated apoptosis in human prostate cancer
cells. PeerJ. 1:e1442013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cristofanon S and Fulda S: ABT-737
promotes tBid mitochondrial accumulation to enhance TRAIL-induced
apoptosis in glioblastoma cells. Cell Death Dis. 3:e4322012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yu DH, Ma CH, Yue ZQ, Yao X and Mao CM:
Protective effect of naringenin against lipopolysaccharide-induced
injury in normal human bronchial epithelium via suppression of MAPK
signaling. Inflammation. 38:195–204. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kapoor R, Rizvi F and Kakkar P: Naringenin
prevents high glucose-induced mitochondria-mediated apoptosis
involving AIF, Endo-G and caspases. Apoptosis. 18:9–27. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kruiswijk F, Labuschagne CF and Vousden
KH: p53 in survival, death and metabolic health, A lifeguard with a
licence to kill. Nat Rev Mol Cell Biol. 16:393–405. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Warfel NA and Kraft AS: PIM kinase (and
Akt) biology and signaling in tumors. Pharmacol Ther. 151:41–49.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Alam MA, Subhan N, Rahman MM, Uddin SJ,
Reza HM and Sarker SD: Effect of citrus flavonoids, naringin and
naringenin, on metabolic syndrome and their mechanisms of action.
Adv Nutr. 5:404–417. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sabarinathan D, Mahalakshmi P and Vanisree
AJ: Naringenin promote apoptosis in cerebrally implanted C6 glioma
cells. Mol Cell Biochem. 345:215–222. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ekambaram G, Rajendran P, Devaraja R,
Muthuvel R and Sakthisekaran D: Impact of naringenin on
glycoprotein levels in N-methyl-N'-nitro-N-nitrosoguanidine-induced
gastric carcinogenesis in rats. Anticancer Drugs. 19:885–890. 2008.
View Article : Google Scholar : PubMed/NCBI
|
